ITNS Statement on COVID-19
ITNS is focused on ensuring that the nurses in our community have the knowledge they need to be ready to care for coronavirus disease (COVID-19) patients and to protect themselves from infection.
As the situation evolves, we will continue to monitor updates from the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO), as well as other leading, reputable resources for facts on infectious disease. Please visit the CDC’s coronavirus resource page for the latest updates and prevention information.
ITNS Statement on Racial Inequality
The International Transplant Nurses Society (ITNS) strongly stands on the foundation of equality for all. Equality for every human being, regardless of race, economic status, gender, age, creed, or sexual orientation is at the core of who we are.
The recent events surrounding George Floyd’s tragic death has enhanced the spotlight on the issue of racial inequality, specifically with the African American community. As nurses, we believe that the conversation must continue towards concrete action to address racial disparities and to assure that social determinants of health are actively and intentionally addressed within the United States’ healthcare system.
ITNS is committed to scholarship and evidence through research in further examining racial health inequalities in organ transplantation and providing culturally-tailored education that address disparities and barriers.
As the voice for transplant nurses from around the globe, ITNS is committed to diversity and inclusion. We have made concrete efforts to invite members of all backgrounds to engage and lead ITNS, and we will continue to do so. Our nominations process has evolved to welcome individuals with varied and valuable competencies in order to lead ITNS now and to shape our association into what we need it to become. We will continue to enhance and strategize ways to diversify our membership, leadership, and the transplant nursing profession.
Organ donation and transplantation saves lives and gives hope. The work that we do impacts patients, their families and friends, and us, the nurses who are committed to providing the very best care possible. We look forward to participating and listening to ongoing conversations from advocates, organizers, and elected officials on how we can support solutions towards racial equity.
Joyce Trompeta, PhD PNP FAAN
Joe Lindahl, MA CAE
2020 ITNS Annual Meeting Abtract Submissions
The ITNS Annual Meeting Planning Commmittee invites abstract applications to present at the 2020 ITNS Annual Meeting from October 22 - 25, 2020 in Rosemont, IL, USA. You're invited to submit an abstract on various topics, including; but not limited to:
- Patient Safety/Quality/Outcomes
- Living Donor
- Liver/Small Bowl
- Career Pathway and Development
- Staff Nurse
- Organ Procurement/Donation
- Young Professional
- Nursing Leadership
- Developing Your Transplant Nursing Workforce
- Operational Excellence Case Studies
- Diversity and Inclusion
- Innovative Practices
The deadline to submit is Wednesday, January 8, 2020 at 11:59 PM (CST USA). Late submissions will not be accepted and there will be no exceptions.
- All abstracts must be submitted in English.
- Abstracts MUST be BLINDED and must not refer to the organization, author, or location, in the title, presenter information, and abstract text, etc. Any unblinded abstracts will be immediately disqualified.
- Each section of the abstract submission form must have a completed entry. Any incomplete abstracts will be disqualified.
- Utilize APA format for references in the Bibliography section.
- Biographical Data and Conflict of Interest Disclosure (BIO/COI) forms must be completed for the main presenter, speakers, and co-authors prior to submission.
- All conference registration, travel, and hotel costs are paid by the presenter(s).
- The abstract title, speaker information (including credentials), and abstract descriptions will appear in all conference materials exactly as submitted. No title changes can be made once the abstract has been submitted. Submitters are asked to determine the final title, proofread the application for typographical errors and verify the accuracy of the speaker listings and abstract title and content before the abstract is submitted.
- The main presenter contact will be responsible for meeting all deadlines and requirements regarding the abstract. Failure to meet deadlines and requirements
- The main presenter is responsible for notifying ITNS Staff of any changes, additions or corrections in main presenter, speaker, or contributor names, paper titles, or availability to present the submitted paper/poster at the assigned date and time. Unless otherwise noted on the abstract, the main presenter will be considered the only contact.
- By submitting the abstract, the main presenter agrees to attend the Annual Meeting to present the abstract if accepted, or coordinate for another colleague to present the abstract.
- The main presenter acknowledges access to the following audio-visual aids for the presentation: scree, podium microphone, projection unit, and laptop.
- All presentations that include patient specific information and/or pictures (research studies, case studies, or quality improvement initiatives must 1) meet your institution's criteria for human subject protection, 2) have institutional Review Board (IRB) approval, and 3) Comply with HIPAA regulations - United States Health Insurance Portability and Accountability Act of 1996.
Other Submission Acceptance Notices:
There is no limit to the amount of abstracts a person may submit, but the Annual Meeting Planning Committee will only accept a maximum of two (2) abstracts from a single person listed as the main presenter or poster presenter, regardless of the format of the abstract (podium presentation or poster presentation).
- If you accept your invitation to present your abstract and later withdraw, the author will not be considered for abstract selection for two years.
Concurrent 30 Minute Session: A 30 minute session presentation of a topic that consists of lecture/discussions. Authors must be willing to modify the content to fit the appropriate format. Presentation delivered within a 30 minute time frame: 25 minute presentation followed by 5 minutes for Q&A.
Poster Presentation: Presenters are assigned specific times to stand by their poster and answer questions posed by passing colleagues during the conference. The visual poster presentation will be 4'x8' size of research, QI, education, or leadership findings by an individual or representatives of a team.
Pre-Conference: A 2 or 4 hour session presentation of a topic that consists of lecture/discussions. Authors must be willing to modify the content to fit the appropriate format. This session will be delivered on Thursday, Oct. 22.
When submitting an abstract, please classify the session according to attendee expertise levels, not the level of the presenter.
Beginner: New to the field, topic or to the care of transplant candidates and/or recipients.
Intermediate: Has worked in the field and is proficient in caring for transplant candidates and/or recipients.
Advanced: Has extensive experience and expertise in caring for transplant candidates and/or recipients or is an advanced practice nurse (e.g., clinical nurse specialist, nurse practitioner).
Main Presenter: Is the main presenter of a submitted abstract and will attend the meeting and present.
Co-Presenter: Are individuals who will be attending the meeting and will be presenting with the main presenter.
Poster Presenter: Is the main poster presenter of a submitted abstract and will attend the meeting, set up, and present the poster.
Co-Poster Presenter: Are individuals who will be attending the meeting and will be presenting with the poster presenter.
Contributor: Are individuals who contribute data, educational planning, or research towards the submitted abstract but will not be presenting.